Form 4: Fulgent Genetics CSO Sells Shares for Tax Obligations

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 943 shares of common stock for $21.4847 per share to cover tax withholding obligations from RSU vesting.

Summary

• Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, Inc. (FLGT), sold 943 shares of common stock.
• The transaction occurred on August 27, 2025, at a weighted-average price of $21.4847 per share, with individual sales ranging from $21.28 to $21.66.
• The sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) that were granted on February 26, 2024.
• Following this transaction, Gao beneficially owns 958,148 shares of Fulgent Genetics common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine, tax-related sale of shares by an insider, which does not typically indicate a change in company fundamentals or management's outlook.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, tax-related sale of a small number of shares relative to the total outstanding, and it was conducted under a pre-arranged plan (10b5-1).

Key Dates

Recommendation

The filing details a routine, tax-related sale of a small number of shares by a Chief Scientific Officer, executed under a pre-arranged 10b5-1 plan. This type of transaction is common for executives and does not typically signal a change in the company's fundamental outlook or performance. Therefore, it provides no new information to warrant a change in investment thesis, suggesting a 'hold' recommendation.

Keywords

Fulgent Genetics, FLGT, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Hanlin Gao, Chief Scientific Officer